The A1BG Gene: Alpha-1-B Glycoprotein

Description

The A1BG gene provides instructions for creating a plasma protein known as alpha-1-B glycoprotein (A1BG). Synthesized primarily by the liver and subsequently secreted into human blood plasma, this protein consists of a single polypeptide chain arranged into five repeating structural domains. A1BG belongs to the Immunoglobulin Supergene Family, sharing notable sequence similarities with the variable regions of antibodies—a structure that suggests an evolutionary link to immune regulation. Biochemically, A1BG acts as a specific binding partner to Cysteine-Rich Secretory Protein 3 (CRISP-3) in circulation, a protective mechanism believed to neutralize the potentially toxic effects of free, unbound CRISP-3.

Associated Diseases

• Cancer (NSCLC and PDAC): Elevated baseline levels of A1BG in blood serum are frequently observed in patients with non-small cell lung cancer (NSCLC). Additionally, A1BG is highly overexpressed alongside markers like MMP-9 in the pancreatic juice of individuals with Pancreatic Ductal Adenocarcinoma (PDAC), making it a candidate diagnostic biomarker.

• Kidney Disease (SRNS): A specific 13.8 kDa urine fragment of the A1BG protein serves as a highly precise marker for Steroid-Resistant Nephrotic Syndrome (SRNS). Because it presents prominently in steroid-resistant pediatric kidney disorders but is absent in steroid-sensitive cases, it assists in predicting therapeutic responses.

• Rheumatoid Arthritis: A1BG levels are noticeably increased within the synovial fluid of individuals suffering from rheumatoid arthritis, highlighting its involvement in localized inflammatory and joint degradation pathways.

• Cardiovascular Disease & Response: Genetic variations (polymorphisms) within the A1BG gene are linked to altered individual responses to antihypertensive medications, illustrating its relevance to personalized cardiovascular health.

Did You Know?

• Mysterious Function: Despite being discovered and mapped decades ago, the exact primary physiological function of A1BG remains one of genomics‘ modern mysteries, fueling active ongoing research.

• Sex-Specific Cardiovascular Roles: Animal model knockouts have revealed surprising sex-based variances: female mice lacking the A1BG gene display significantly compromised cardiac function, whereas male knockouts remain unaffected.

• Post-Translational Customization: The protein features four distinct N-glycosylation sites. These cellular updates modify its structural shape, allowing it to safely dock with other vital proteins floating in the blood.

• Complex Proteomic Interactions: Beyond its primary bond with CRISP-3, A1BG interacts dynamically with an array of other circulatory proteins, indicating a broader role as a molecular shield or balance mechanism in human plasma.

In Summary:

While the A1BG gene does not control an independent major biological outcome like insulin, its structural links to human antibodies and its exact spikes during cancer, steroid-resistant kidney conditions, and arthritis make it an invaluable focus area for modern preventive genomics and advanced biomarker discovery.

🔒 Login to View More

Related Products

• 🧬 Genomepatri® – Discover your underlying inherited risks, health predispositions, and personalized drug responses across thousands of genetic variations.

• 🔬 WES (Whole Exome Sequencing) – Map all protein-coding regions of your genome to reveal critical clinical liabilities, rare variants, and deep health insights.

Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.